Edgar M Carvalho Selected Research

Leishmaniasis

11/2022	Immune Response to LinB13, a Lutzomyia Intermedia Salivary Protein Correlates With Disease Severity in Tegumentary Leishmaniasis.
5/2021	Anti-Leishmania IgG is a marker of disseminated leishmaniasis caused by Leishmania braziliensis.
1/2021	High Anti-Leishmania IgG Antibody Levels Are Associated With Severity of Mucosal Leishmaniasis.
1/2020	Human CD8+ T Cells Release Extracellular Traps Co-Localized With Cytotoxic Vesicles That Are Associated With Lesion Progression and Severity in Human Leishmaniasis.
12/2019	Investigation of the pathways related to intrinsic miltefosine tolerance in Leishmania (Viannia) braziliensis clinical isolates reveals differences in drug uptake.
1/2018	Susceptibility of dendritic cells from individuals with schistosomiasis to infection by Leishmania braziliensis.
1/2018	The miRNA 361-3p, a Regulator of GZMB and TNF Is Associated With Therapeutic Failure and Longer Time Healing of Cutaneous Leishmaniasis Caused by L. (viannia) braziliensis.
1/2017	CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1β production.
11/2015	Role of urine neutrophil gelatinase-associated lipocalin in the early diagnosis of amphotericin B-induced acute kidney injury.
9/2015	Treatment of Disseminated Leishmaniasis With Liposomal Amphotericin B.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Edgar M Carvalho Research Topics

Disease

54	Cutaneous Leishmaniasis 11/2022 - 01/2002
34	Leishmaniasis 11/2022 - 12/2002
28	Infections 11/2022 - 05/2003
8	Inflammation (Inflammations) 04/2022 - 10/2008
7	Ulcer 01/2020 - 01/2002
7	Asthma (Bronchial Asthma) 02/2017 - 05/2003
6	Spinal Cord Diseases 12/2018 - 01/2004
6	Schistosomiasis (Bilharziasis) 01/2018 - 01/2002
6	Schistosomiasis mansoni 01/2014 - 01/2004
5	Hypersensitivity (Allergy) 01/2021 - 07/2005
5	Fibrosis (Cirrhosis) 01/2021 - 01/2004
3	Overactive Urinary Bladder (Overactive Bladder) 03/2018 - 11/2012
3	Tuberculosis (Tuberculoses) 01/2018 - 08/2012
3	Disease Progression 04/2011 - 01/2007
3	Candidiasis (Moniliasis) 07/2005 - 01/2002
3	Visceral Leishmaniasis (Kala Azar) 01/2003 - 01/2002
2	Arthralgia (Joint Pain) 02/2021 - 12/2010
2	Vomiting 02/2021 - 12/2010
2	Nausea 02/2021 - 12/2010
2	Necrosis 12/2020 - 01/2020
2	Neoplasms (Cancer) 12/2020 - 05/2010
2	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 12/2018 - 01/2006
2	Skin Ulcer 01/2018 - 01/2002
2	Parasitic Diseases (Parasitic Disease) 01/2018 - 09/2011
2	Leukemia 01/2017 - 03/2015
2	Communicable Diseases (Infectious Diseases) 09/2011 - 10/2008
2	Abdominal Pain (Pain, Abdominal) 12/2010 - 01/2002
2	HTLV-I Infections (HTLV-I Infection) 10/2008 - 01/2004
1	Myalgia 02/2021
1	Portal Hypertension 01/2021
1	Overweight 01/2021
1	Obesity 01/2021
1	Bacterial Infections (Bacterial Infection) 12/2020
1	Hepatitis C 02/2017
1	Hepatitis B 02/2017
1	Virus Diseases (Viral Diseases) 02/2017
1	Dizziness (Lightheadedness) 01/2017

Drug/Important Bio-Agent (IBA)

33	CytokinesIBA 05/2021 - 01/2002
28	AntigensIBA 01/2021 - 12/2002
17	Interleukin-10 (Interleukin 10)IBA 01/2021 - 01/2002
14	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2015 - 01/2002
12	AntimonyIBA 01/2022 - 11/2004
9	Interleukin-5 (Interleukin 5)IBA 01/2021 - 01/2002
6	Interferon-gamma (Interferon, gamma)IBA 03/2015 - 01/2002
5	Immunoglobulin G (IgG)IBA 11/2022 - 02/2012
5	Interleukin-17 (Interleukin 17)IBA 04/2022 - 07/2009
5	ChemokinesIBA 04/2022 - 09/2011
5	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2021 - 01/2002
5	miltefosine (Impavido)IBA 10/2021 - 12/2010
5	Interleukin-6 (Interleukin 6)IBA 12/2020 - 08/2006
4	Interleukin-13IBA 01/2021 - 01/2004
4	Pharmaceutical PreparationsIBA 12/2019 - 07/2005
4	InterleukinsIBA 07/2015 - 01/2004
3	VaccinesIBA 04/2022 - 01/2002
3	AntibodiesIBA 05/2021 - 01/2002
3	InflammasomesIBA 01/2021 - 01/2017
3	HLA-DR Antigens (HLA-DR)IBA 01/2018 - 01/2014
3	AllergensIBA 02/2017 - 05/2003
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 11/2015
3	Pentoxifylline (Trental)FDA LinkGeneric 04/2014 - 03/2007
3	Immunoglobulin E (IgE)IBA 04/2004 - 01/2002
2	Interleukin-12 (IL 12)IBA 04/2022 - 01/2014
2	Granzymes (Granzyme)IBA 04/2022 - 01/2020
2	Meglumine AntimoniateIBA 02/2021 - 01/2018
2	Interleukin-4 (Interleukin 4)IBA 01/2021 - 11/2004
2	Immunologic Factors (Immunomodulators)IBA 01/2021 - 01/2016
2	InterferonsIBA 12/2020 - 01/2018
2	Cholinergic Antagonists (Anticholinergics)IBA 03/2018 - 04/2007
2	Fluconazole (Zonal)FDA LinkGeneric 01/2017 - 07/2005
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016 - 02/2007
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 12/2002
2	Biological ProductsIBA 01/2015 - 10/2008
2	Tuberculin (PPD)IBA 08/2012 - 09/2003
2	Interleukin-10 ReceptorsIBA 01/2009 - 12/2005
1	Salivary Proteins and PeptidesIBA 11/2022
1	CelluloseIBA 01/2022
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 12/2021
1	Macrophage Colony-Stimulating FactorIBA 02/2021
1	LeptinIBA 01/2021
1	Leukotriene B4IBA 12/2020
1	Dinoprostone (PGE2)FDA Link 12/2020
1	Glucose (Dextrose)FDA LinkGeneric 12/2020
1	DNA (Deoxyribonucleic Acid)IBA 10/2020
1	Glyburide (Glibenclamide)FDA LinkGeneric 01/2020
1	PerforinIBA 01/2020
1	Tyr sulfate(1)- enkephalinamide-Leu (LETS)IBA 01/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019
1	Viral AntigensIBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Tamoxifen FDA LinkGeneric 01/2018
1	Pyrin Domain-Containing 3 Protein NLR FamilyIBA 01/2018
1	Interleukin-12 Subunit p40IBA 01/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2017

Therapy/Procedure

13	Therapeutics 01/2021 - 01/2003
2	Aftercare (After-Treatment) 03/2016 - 05/2009
1	Precision Medicine 11/2019
1	Conservative Treatment 03/2018
1	Physical Therapy Modalities (Physical Therapy Technique) 03/2018
1	Renal Dialysis (Hemodialysis) 02/2017
1	Blood Transfusion (Blood Transfusions) 02/2017